Pharming Group (PHAR) Earnings Date, Estimates & Call Transcripts $7.30 +0.22 (+3.11%) (As of 10:25 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateOct. 24EstimatedActual EPS (Aug. 1) -$0.01 Missed By -$0.01 Get Pharming Group Earnings AlertsEnter your email address below to receive the latest news and earnings results for PHAR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePHAR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PHAR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Sasco Gold LLCSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... [RUSH MY FREE GUIDE] Pharming Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.01$0.01$0.01 Q2 20241$0.02$0.02$0.02 Q3 20241$0.11$0.11$0.11 Q4 20241$0.12$0.12$0.12 FY 20244$0.26$0.26 $0.26PHAR Earnings Date and InformationPharming Group last posted its earnings data on August 1st, 2024. The reported ($0.01) earnings per share for the quarter. The company earned $74.09 million during the quarter, compared to analyst estimates of $71.95 million. Pharming Group has generated ($0.16) earnings per share over the last year (($0.16) diluted earnings per share). Earnings for Pharming Group are expected to grow in the coming year, from ($0.15) to $0.12 per share. Pharming Group has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off prior year's report dates.Read More Pharming Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/24/2024(Estimated)------- 8/1/2024Q2 2024-($0.01)($0.01)($0.01)$71.95 million$74.09 million5/8/2024Q1 2024$0.01($0.19)($0.20)($0.19)$68.43 million$55.59 million3/14/2024Q4 2023$0.05($0.03)($0.08)($0.02)$71.83 million$81.20 million10/26/2023Q3 2023$0.13$0.05($0.08)$0.05$61.67 million$66.66 million8/3/2023Q2 2023($0.02)$0.02+$0.04$0.02$51.80 million$54.90 million5/11/2023Q1 2023($0.01)($0.17)($0.16)($0.17)$48.15 million$42.54 million Get the Latest News and Ratings for PHAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 3/16/2023Q4 2022$0.01($0.19)($0.20)($0.17)$57.94 million$54.62 million10/27/2022Q3 2022$0.02$0.13+$0.11$0.13$53.52 million$54.24 million8/4/2022Q2 2022$0.01$0.04+$0.03($0.14)$51.99 million$50.15 million5/12/2022Q1 2022-$0.05+$0.05$0.05$48.00 million$46.62 million3/17/2022Q4 2021$0.01$0.01-$0.01$57.59 million$52.77 million10/28/2021Q3 2021-($0.04)($0.04)($0.04)-$28.70 million8/5/2021Q2 2021$0.01$0.06+$0.05$0.06$64.13 million$49.60 million5/13/2021Q1 2021$0.01$0.13+$0.12$0.13$60.50 million$43.45 million3/4/2021Q4 2020$0.01$0.13+$0.12$0.13$61.69 million$60.80 million Pharming Group Earnings - Frequently Asked Questions When is Pharming Group's earnings date? Pharming Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off last year's report dates. Learn more on PHAR's earnings history. What guidance has Pharming Group issued on next quarter's earnings? Pharming Group issued an update on its FY 2024 earnings guidance on Thursday, August, 1st. The company issued revenue guidance of $280.0 million-$295.0 million. How much revenue does Pharming Group generate each year? Pharming Group (NASDAQ:PHAR) has a recorded annual revenue of $245.32 million. How much profit does Pharming Group generate each year? Pharming Group (NASDAQ:PHAR) has a recorded net income of -$10.55 million. PHAR has generated -$0.16 earnings per share over the last four quarters. What is Pharming Group's EPS forecast for next year? Pharming Group's earnings are expected to grow from ($0.15) per share to $0.12 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Mirum Pharmaceuticals Earnings Results Zai Lab Earnings Results Supernus Pharmaceuticals Earnings Results Galapagos Earnings Results Kiniksa Pharmaceuticals Earnings Results Ligand Pharmaceuticals Earnings Results Akero Therapeutics Earnings Results Keros Therapeutics Earnings Results Structure Therapeutics Earnings Results Arvinas Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Is Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 EarningsNVIDIA: Analysts Bullish Ahead of Earnings - Is It a Buy Now? This page (NASDAQ:PHAR) was last updated on 9/9/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredWall Street Insider Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
